FORMULARY WATCH

DRUG PRICING

TODAY'S HEADLINES

Pricing report blasts asthma drug cost

In the latest controversy over drug pricing, an organization said that the price of one injectable drug indicated for severe asthma patients with eosinophilic inflammation, is far over-priced. Read more

Keytruda approved as first-line melanoma treatment

Sales of Merck's Keytruda (pembrolizumab) are expected to increase, after FDA approved the drug for first-line treatment of melanoma. Read more

CONTINUING PHARMACY EDUCATION

December 2015

MTM essentials for cough management

Pharmacists can help patients with the various management options for the most common causes of cough. More

How to help IPF patients — from their point of view

A patient with idiopathic pulmonary fibrosis (IPF) talks to FormularyWatch. Details

December 30, 2015

Valeant responds to drug price concerns with cuts

5 things to know about the new lung cancer drug

Click to contact the editorial team. Click to contact the sales team.

Part of the

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us